Prostate cancer research and treatment program at Memorial Sloan Kettering
SPORE in Prostate Cancer
This program works on better blood tests, genetic analyses, and new treatments to help men with prostate cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11173716 on NIH RePORTER |
What this research studies
This program focuses on the genetics and molecular drivers of prostate cancer to create blood-based tests and risk models that tell who needs more or less treatment. You might be asked to give blood or tumor samples and have your cancer's DNA analyzed to help match you to the right care. The team also tests new drug targets in the lab and then in clinical trials designed for people with specific tumor features. The goal is to tailor treatments to each patient's risk and biology to improve outcomes and avoid unnecessary therapy.
Who could benefit from this research
Good fit: Ideal participants are men with prostate cancer—ranging from newly diagnosed localized cases at risk for spread to men with advanced or metastatic disease—who can provide blood or tissue samples and consider trial participation.
Not a fit: People without prostate cancer, women, or those unable or unwilling to provide samples or join clinical studies are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this work could produce tests that separate harmless from dangerous prostate cancers and new therapies that improve survival while reducing overtreatment.
How similar studies have performed: Prior work from this SPORE has already produced new diagnostic blood tests, prognostic models, and clinical drug trials that have influenced care worldwide, so the approach builds on proven successes.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Chen, Yu — Sloan-Kettering Inst Can Research
- Study coordinator: Chen, Yu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.